Address
:
[go:
up one dir
,
main page
]
Include Form
Remove Scripts
Session Cookies
Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q51830138)
Watch
English
Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.
scientific article published in May 2010
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20417413
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20417413%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
title
Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20417413
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20417413%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
main subject
vaccine
1 reference
based on heuristic
inferred from title
author
Luigi Buonaguro
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20417413
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20417413%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
Gabriella Scarlatti
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20417413
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20417413%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
author name string
Anna Laura Ross
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20417413
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20417413%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
Andreas Bråve
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20417413
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20417413%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
Amapola Manrique
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20417413
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20417413%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
publication date
1 May 2010
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20417413
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20417413%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
published in
Lancet Infectious Diseases
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20417413
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20417413%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
volume
10
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20417413
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20417413%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
issue
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20417413
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20417413%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
page(s)
305-316
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20417413
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20417413%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
cites work
Salvage antiretroviral therapy in HIV infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long term adverse effects related to nucleoside reverse transcriptase inhibitors: clinical impact of mitochondrial toxicity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Broad HIV-1 neutralization mediated by CD4-binding site antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HIV vaccine research: the way forward
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Trials of vaccine against AIDS to begin in humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Heterologous prime-boost vaccination.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HIV Vaccines: A Global Perspective
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Post-step modifications for research on HIV vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Phase II Study of Two HIV Type 1 Envelope Vaccines, Comparing Their Immunogenicity in Populations at Risk for Acquiring HIV Type 1 Infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Report on the AIDS Vaccine 2008 Conference
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of AIDS virus envelope gene in recombinant vaccinia viruses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia viruses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OA02-06 LB. Recombinant modified Vaccinia virus ankara expressing HIV-1 genes activates NK subset capable of controlling HIN infection in vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
NYVAC: a highly attenuated strain of vaccinia virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Attenuated measles virus as a vaccine vector
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OA021-02. Replicating measles-SHIV vaccine induces long term preservation of central memory CD4 cells in the gut of vaccinated macaques challenged with SHIV
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A new generation of animal cell expression vectors based on the Semliki Forest virus replicon
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sindbis virus: an efficient, broad host range vector for gene expression in animal cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Characterization of immune responses elicited in macaques immunized sequentially with chimeric VEE/SIN alphavirus replicon particles expressing SIVGag and/or HIVEnv and with recombinant HIVgp140Env protein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
P19-14. Recombinant alphavirus replicon particles as a platform to evaluate immunogenicity of early transmitted clade C virus envelopes.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Replication-defective vector based on a chimpanzee adenovirus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Engineered adenovirus serotypes for overcoming anti-vector immunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
DNA vaccines: ready for prime time?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OA05-02. Analysis of DNA compared to Ad5 vaccination, as single and mixed modalities, demonstrates robust induction of cellular immune responses in macaques
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Persistent immune responses induced by a human immunodeficiency virus DNA vaccine delivered in association with electroporation in the skin of nonhuman primates
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OA05-03. Efficacy study of a T-cell-based DNA vaccine delivered by intradermal electrotransfer in macaques.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human Immunodeficiency Virus Type 1 Subtype B Ancestral Envelope Protein Is Functional and Elicits Neutralizing Antibodies in Rabbits Similar to Those Elicited by a Circulating Subtype B Envelope
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diversity considerations in HIV-1 vaccine selection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evolutionary and immunological implications of contemporary HIV-1 variation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Consensus and Ancestral State HIV Vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ancestral and consensus envelope immunogens for HIV-1 subtype C.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased detection of HIV-specific T cell responses by combination of central sequences with comparable immunogenicity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The challenge of HIV-1 subtype diversity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Development of a quasispecies of human immunodeficiency virus type 1 in vivo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Viral quasispecies.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antibody neutralization and escape by HIV-1
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
P10-07. Extremely rapid degranulation of NK cells activated by HIV-specific antibody dependent cellular cytotoxicity.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OA021-05. Insertion of the HIV-1 gp41 epitopes 2F5 and 4E10 into the membrane-proximal region of the vesicular stomatitis virus glycoprotein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitope.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human monoclonal antibody 2909 binds to pseudovirions expressing trimers but not monomeric HIV-1 envelope proteins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Structure-based antigen design: a strategy for next generation vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Structure of a V3-containing HIV-1 gp120 core
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
P04-38. Crystal structure of gp120 in complex with the CD4-binding-site antibody b13 suggests precise targeting is needed for neutralization.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
African non human primates infected by SIV - why don't they get sick? Lessons from studies on the early phase of non-pathogenic SIV infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systems biology of innate immunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Th2 polarization in peripheral blood mononuclear cells from human immunodeficiency virus (HIV)-infected subjects, as activated by HIV virus-like particles
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OA07-02. Adenovirus vectors induce expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1 infection.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OA06-06 LB. Evidence of vaccine-induced changes in breakthrough HIV-1 strains from the Step trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970069-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1473-3099(10)70069-4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20417413
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20417413%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
PubMed publication ID
20417413
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20417413
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20417413%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit